Clinical Trials Browser

OTHER × Hemorrhagic Stroke × Clear all

Brain Injuries, Traumatic, Hemorrhagic Stroke, Brain Neoplasms

NCT05945784 2023-12-06

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Brain Injuries, Traumatic, Ischemic Stroke, Hemorrhagic Stroke, Amyotrophic Lateral Sclerosis, Ehlers-Danlos Syndrome, Graves Disease, Multiple Sclerosis, Muscular Dystrophies, Myasthenia Gravis, Spinal Cord Injuries, Muscle Weakness, Guillain-Barre Syndrome, Stroke

NCT02626377 2023-10-23

ICE

Phase NA Terminated

186 enrolled

BreastGastrointestinalGenitourinary

Ischemic Stroke, Hemorrhagic Stroke, Alzheimer Disease, Breast Neoplasms, Heart Diseases, Macular Degeneration, Parkinson Disease, Prostatic Neoplasms, Colorectal Neoplasms

NCT05148663 2023-09-01

CCM Blood Biomarker Validation Study

Terminated

12 enrolled

CNS

Hemorrhagic Stroke, Hemangioma, Cavernous, Central Nervous System

NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Phase EARLY_PHASE1 Completed

10 enrolled

CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

NCT00390962 2008-09-23

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Completed

469 enrolled

Breast

Hemorrhagic Stroke, Carcinoma, Intraductal, Noninfiltrating, Ischemic Attack, Transient, Diabetes Insipidus, Inappropriate ADH Syndrome, Stroke

Clinical Trials

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

ICE

CCM Blood Biomarker Validation Study

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)